# Mclaughlin Gormley King Company – FDA Inspection, Dec 8, 2021

Source: https://www.keypedia.com/records/fda_inspections/mclaughlin-gormley-king-company/20969a2d-6174-4d37-8c64-63269b1a110c
Source feed: FDA_Inspections

> FDA inspection 1158364 of Mclaughlin Gormley King Company, December 08, 2021. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1158364
- Company Name: Mclaughlin Gormley King Company
- Inspection Date: 2021-12-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 950797 - 2015-11-12
- FDA Inspection 889103 - 2014-07-30
- FDA Inspection 626858 - 2009-11-09

Company: https://www.keypedia.com/companies/mclaughlin-gormley-king-company/7f808845-6551-41f6-bb65-9ce238910788

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c